breast cancer Archives
3-D imaging enhances options for breast cancer screening
Mar. 27, 2014—The Vanderbilt Breast Center at Vanderbilt Health One Hundred Oaks has added tomosynthesis mammography, an imaging technique that creates a three-dimensional image of breast tissue, to help screen patients for breast cancer.
Studies shed new light on breast cancer development
Feb. 20, 2014—Rebecca Cook, Ph.D., assistant professor of Cancer Biology, has spent her life trying to understand what makes things grow, from seedlings in soil to tumor cells in the body.
Cancer drug enhances cognition
Dec. 16, 2013—The breast cancer drug tamoxifen improves cognitive performance in post-menopausal women.
VU study sheds new light on DNA replication
Nov. 7, 2013—David Cortez, Ph.D., and his Vanderbilt colleagues report new findings that shed light on fundamental processes involved in DNA replication and have implications for cancer therapies that target these processes.
New technique tracks breast cancer subtypes, treatment effectiveness
Oct. 17, 2013—A group of Vanderbilt researchers has used laser technology and a custom-built multiphoton microscope to distinguish breast cancer subtypes and determine if specific therapies are working against the cancer cells in as little as two days.
Komen grants bolster breast cancer research
Aug. 15, 2013—Vanderbilt-Ingram Cancer Center investigators are receiving $1 million in breast cancer research grant funds from Susan G. Komen, the largest nonprofit foundation supporting breast cancer research.
Predicting cancer’s response to therapy
Jun. 24, 2013—Researchers are developing imaging methods to predict patient outcome early in the course of chemotherapy for breast cancer – to allow clinicians to adjust therapy for patients who are not responding.
Disease linked to cell traffic jams
Jun. 20, 2013—Diseases associated with mutations and changes in expression of the protein caveolin may result from faulty trafficking of the protein to the cell surface.
Breast cancer study explores therapy to slow recurrence
Mar. 21, 2013—Many patients with triple-negative breast cancer (TNBC) have recurrence of their disease after an initial response to chemotherapy because the cancer cells have become resistant to treatment. TNBC has a lower survival rate because of this pattern of resistance and there are no targeted agents to treat this form of breast cancer.
Potent genetic risk factor for breast cancer identified
Feb. 28, 2013—Researchers at Vanderbilt University have found a powerful new genetic risk factor for breast cancer.
Memorial Gym to go pink for breast cancer awareness
Feb. 7, 2013—The Vanderbilt Commodores Women’s Basketball team will be decked out in pink uniforms when they take the home court this Sunday, Feb. 10, at 3 p.m., in a matchup against the Kentucky Wildcats.
Vanderbilt study finds diverse genetic alterations in triple-negative breast cancers
Dec. 7, 2012—Most triple-negative breast cancer patients who were treated with chemotherapy to shrink the tumor prior to surgery still had multiple genetic mutations in their tumor cells, according to a study by Vanderbilt-Ingram Cancer Center (VICC) investigators.
